Authors: Anita Wynne, Teri Woo, Michael Millard, Ali Olyaei
ISBN-13: 9780803613614, ISBN-10: 080361361X
Format: Hardcover
Publisher: F. A. Davis Company
Date Published: February 2007
Edition: 2nd Edition
Michael Millard, BS Pharm, MS Pharm Adm, Instructor, School of Nursing, University of Portland, Portland, Oregon
Teri Moser Woo, RN, MS, CPNP, Assistant Professor, Family Nursing, University of Portland, Portland, Oregon
Anita Lee Wynne, CRNP, PhD, Associate Professor, School of Nursing, University of Portland, Portland, Oregon
This reference comprises a thorough, current and usable pharmacology text to help the nurse practitioner address the challenge of acquiring and maintaining knowledge in the face of the number of new drugs coming on the market each year. Wynne (nursing, U. of Portland), Teri Moser Woo (Oregon Health Sciences U.) and Michael Millard (pharmacy, Sacred Heart Medical Center) present 49 contributions that cover the foundation material, pharmacotherapeutics with single and multiple drugs, and special drug treatment considerations.
Annotation c. Book News, Inc., Portland, OR (booknews.com)
Reviewer: Candis Morrison, PhD, CRNP (Johns Hopkins University School of Nursing)
Description: This pharmacotherapeutics book presents content in both narrative and tabular format and organizes it into four units, including foundation, pharmacotherapeutics with single drugs, pharmacotherapeutics with multiple drugs, and special drug treatment considerations.
Purpose: The stated purpose is to provide the reader with the current pharmacologic information required to practice. Though there are numerous reference books available, there are few that include nurse practitioner specific role issues and effectively put prescribing in perspective.
Audience: The target audiences are the primary care nurse practitioner student and the nurse practitioner practicing in the primary care setting. Much of the material is also useful to other groups of advanced practice nurses, especially clinical specialists.
Features: Unit one provides specifics about nurse practitioner prescribing, i.e. collaboration with other disciplines. There are issues unique to advanced practice nurses that are not covered in other pharmacology texts or resource books. The brief synopsis of the efforts to gain the privilege, and a discussion regarding the responsibilities that accompany it, are included. A user-friendly review of pharmacodynamics and kinetics is presented. This is especially helpful for those who are several years removed from their basic pharmacology course. Principles of rational drug selection and the legal and professional issues unique to advanced practice nurses are well covered. Ethnic and cultural differences and patient variables that can affect health outcomes are presented as are use of the Internet and other technologies. Categories of over the counter preparations as well as common herbal preparations are presented. Units 2 and 3 actually present the information on the specific prescription pharmacologic agents; the former organized by body system, and the latter by symptom or specific disease. Each agent is organized into information on pharmacodynamics, kinetics, and therapeutics. In addition, agents in each category are presented in tabular format to facilitate comparisons. Unit 4 goes into depth on specific populations, including women, children, elders and the chronically ill.
Assessment: This book provides the nurse practitioner with drug specific information required to prescribe safely and effectively. It also provides role specific information to enhance professionalism in prescribing. The first and last units provide content that is not available in most pharmacology books. It is an excellent reference book.
Unit I | The Foundation | 1 |
Ch. 1 | The Role of the Nurse Practitioner as Prescriber | 3 |
Ch. 2 | Review of Basic Principles of Pharmacology | 9 |
Ch. 3 | Rational Drug Selection | 25 |
Ch. 4 | Legal and Professional Issues in Prescribing | 39 |
Ch. 5 | Adverse Drug Reactions | 49 |
Ch. 6 | Factors that Foster Positive Outcomes | 57 |
Ch. 7 | Cultural and Ethnic Influences in Pharmacotherapeutics | 63 |
Ch. 8 | Nutrition and Drug Therapy | 73 |
Ch. 9 | Pharmacology in Complementary Medicine | 79 |
Ch. 10 | Information Technology and Pharmacology | 91 |
Ch. 11 | Over-the-Counter Medications | 113 |
Unit II | Pharmacotherapeutics With Single Drugs | 129 |
Ch. 12 | Drugs Affecting the Autonomic Nervous System | 131 |
Ch. 13 | Drugs Affecting the Central Nervous System | 185 |
Ch. 14 | Drugs Affecting the Cardiovascular and Renal Systems | 249 |
Ch. 15 | Drugs Affecting the Respiratory System | 311 |
Ch. 16 | Drugs Affecting the Hematopoietic System | 371 |
Ch. 17 | Drugs Affecting the Immune System | 399 |
Ch. 18 | Drugs Affecting the Gastrointestinal System | 437 |
Ch. 19 | Drugs Affecting the Endocrine System | 485 |
Ch. 20 | Drugs Affecting the Reproductive System | 543 |
Ch. 21 | Drugs Affecting the Integumentary System | 565 |
Ch. 22 | Drugs Used in Treating Infectious Diseases | 619 |
Ch. 23 | Drugs Used in Treating Inflammatory Processes | 743 |
Ch. 24 | Drugs Used in Treating Eye and Ear Disorders | 781 |
Unit III | Pharmacotherapeutics With Multiple Drugs | 809 |
Ch. 25 | Anemia | 811 |
Ch. 26 | Chronic Stable Angina and Low-Risk Unstable Angina | 825 |
Ch. 27 | Anxiety and Depression | 841 |
Ch. 28 | Asthma and Chronic Obstructive Pulmonary Disease | 857 |
Ch. 29 | Contraception | 885 |
Ch. 30 | Dermatologic Conditions | 899 |
Ch. 31 | Diabetes Mellitus | 939 |
Ch. 32 | Gastroesophageal Reflux and Peptic Ulcer Disease | 959 |
Ch. 33 | Headaches | 977 |
Ch. 34 | Heart Failure | 1003 |
Ch. 35 | Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Disease | 1019 |
Ch. 36 | Hormone Replacement Therapy and Osteoporosis | 1035 |
Ch. 37 | Hyperlipidemia | 1051 |
Ch. 38 | Hypertension | 1069 |
Ch. 39 | Hyperthyroidism and Hypothyroidism | 1089 |
Ch. 40 | Pneumonia | 1105 |
Ch. 41 | Smoking Cessation | 1115 |
Ch. 42 | Sexually Transmitted Diseases and Vaginitis | 1127 |
Ch. 43 | Tuberculosis | 1141 |
Ch. 44 | Upper Respiratory Infections: Viral Upper Respiratory Infection, Sinusitis, Otitis Media, and Otitis Externa | 1155 |
Ch. 45 | Urinary Tract Infections | 1169 |
Unit IV | Special Drug Treatment Considerations | 1183 |
Ch. 46 | Women as Patients | 1185 |
Ch. 47 | Pediatric Patients | 1195 |
Ch. 48 | Geriatric Patients | 1209 |
Ch. 49 | Chronically Ill and Long-Term Care | 1221 |
Index | 1227 |